Filing Details

Accession Number:
0000950103-21-002457
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-17 20:18:54
Reporting Period:
2021-02-12
Accepted Time:
2021-02-17 20:18:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828182 Signify Health Inc. SGFY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672957 Steve Senneff C/O Signify Health, Inc.
800 Connecticut Avenue
Norwalk CT 06854
Pres., Chief Fin. & Admin Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-02-12 98,214 $0.00 98,214 No 4 A Direct
Class B Common Stock Acquisiton 2021-02-12 506,975 $0.01 506,975 No 4 A Direct
Class A Common Stock Acquisiton 2021-02-16 13,900 $24.00 112,114 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Options (Right to Buy) Acquisiton 2021-02-12 883,932 $0.00 883,932 $8.46
Class A Common Stock LLC Units in Cure Aggregator, LLC Acquisiton 2021-02-12 506,975 $0.00 506,975 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
883,932 2029-06-10 No 4 A Direct
506,975 No 4 A Direct
Footnotes
  1. These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in New Remedy Corp.
  2. These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC.
  3. These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
  4. The stock options service-vest in equal installments on each of March 14, 2021, 2022 and 2023 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified multiple of invested capital return thresholds.
  5. The LLC Units service-vest 25% on each of the first four anniversaries of February 18, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.